Why the study?
Does preoperative hypoalbuminemia increase direct treatment costs, length of stay, and readmissions in patients undergoing total hip and knee arthroplasty?
Does preoperative hypoalbuminemia increase direct treatment costs, length of stay, and readmissions in patients undergoing total hip and knee arthroplasty?
Preoperative hypoalbuminemia is a significant predictor of increased direct treatment costs, length of stay, and readmissions following total hip and knee arthroplasty.
Identifies preoperative hypoalbuminemia as a marker for higher resource utilization in arthroplasty;.
BACKGROUND: Hypoalbuminemia (serum albumin < 3.5 g/dL) is associated with increased morbidity and mortality in patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA). However, costs associated with hypoalbuminemia remain unknown. This study investigated the effect of serum albumin on direct treatment costs, length of stay (LOS), and readmissions for primary and revision THA and TKA patients. METHODS: All adult patients at a single institution undergoing primary or revision THA or TKA between January 2014 and December 2016 were retrospectively reviewed. Patients were stratified by preoperative serum albumin level. The primary outcome was total direct costs at index hospitalization. Secondary outcomes included LOS and readmission within 30 days. Multivariable regressions were utilized to adjust for demographics and comorbidities. RESULTS: < 0.001). CONCLUSIONS: Hypoalbuminemia is associated with increased total direct costs, LOS, and readmissions following primary and revision THA and TKA. Future efforts to predict and address total costs should take into consideration the patient's preoperative serum albumin levels.
No takes yet. Share an insight, caveat, or question.
Rudasill et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: